cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.34808/5hnc-4r11
title: Sessile serrated polyp - Female, 38 - Tissue image [6300730028276841]

description: This is the histopathological image of COLON tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 38Clinical description: Polyp of ascending colon.Gender: FemaleDiagnosis:Classification: ICD-O_3.2Classification code: ADENOMAS AND ADENOCARCINOMASDiagnosis: Sessile serrated polypResult of the histopathological examination: Sessile serrated polyp.Sample:Material: FFPECollecting method: Excision of lesionsTopography: DIGESTIVE ORGANSOrgan: COLONTissue: Ascending colonType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/bvq5-1y21
title: Nontoxic multinodular goitre - Female, 46 - Tissue image [6300730028258961]

description: This is the histopathological image of THYROID GLAND tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 46Clinical description: Thyroid goiter.Gender: FemaleDiagnosis:Classification: ICD-10_10-20Classification code: Chapter IV - Endocrine, nutritional and metabolic diseasesDiagnosis: Nontoxic multinodular goitreResult of the histopathological examination: Multinodular goiter.Sample:Material: FFPECollecting method: Surgical specimenTopography: THYROID AND OTHER ENDOCRINE GLANDSOrgan: THYROID GLANDTissue: Thyroid, NOSType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/8gwz-0810
title: Tenosynovial giant cell tumor, localised - Male, 9 - Tissue image [6300730028268441]

description: This is the histopathological image of OTHER AND ILL-DEFINED SITES tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 9Clinical description: Tumor of finger.Gender: MaleDiagnosis:Classification: ICD-O_3.2Classification code: GIANT CELL TUMORSDiagnosis: Tenosynovial giant cell tumor, localisedResult of the histopathological examination: Tenosynovial giant cell tumor, localised (CD68+, CD163+).Sample:Material: FFPECollecting method: Excision of lesionsTopography: OTHER AND ILL-DEFINED SITESOrgan: OTHER AND ILL-DEFINED SITESTissue: Finger, NOSType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/8kmp-mp87
title: Keratoacanthoma - Male, 76 - Tissue image [6300730028254191]

description: This is the histopathological image of SKIN tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 76Clinical description: Light brown lesion of skin of face with dimensions 1,4 x 1,3 x 0,8 cm.Gender: MaleDiagnosis:Classification: ICD-O_3.2Classification code: SQUAMOUS CELL NEOPLASMSDiagnosis: KeratoacanthomaResult of the histopathological examination: Keratoacanthoma.Sample:Material: FFPECollecting method: Excision of lesionsTopography: SKINOrgan: SKINTissue: Skin of faceType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/az05-ee23
title: Seborrhoeic keratosis - Female, 53 - Tissue image [6300730028272721]

description: This is the histopathological image of SKIN tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 53Clinical description: Flat brown lesion of skin of back.Gender: FemaleDiagnosis:Classification: ICD-O_3.2Classification code: SQUAMOUS CELL NEOPLASMSDiagnosis: Seborrhoeic keratosisResult of the histopathological examination: Seborrhoeic keratosis- acanthotic proliferation of small keratinocytes without cytological atypia. Pseudocysts with loose keratin and hyperpigmenation of basal cell layer are present.Sample:Material: FFPECollecting method: Excision of lesionsTopography: SKINOrgan: SKINTissue: Skin of backType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/a1xd-6h40
title: Chronic cholecystitis - Female, 36 - Tissue image [6300730028273371]

description: This is the histopathological image of GALLBLADDER tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 36Clinical description: Chronic cholecystitis.Gender: FemaleDiagnosis:Classification: ICD-10_10-20Classification code: Chapter XI - Diseases of the digestive systemDiagnosis: Chronic cholecystitisResult of the histopathological examination: Chronic cholecystitis (xanthogranulomatous cholecystitis).Sample:Material: FFPECollecting method: Surgical specimenTopography: DIGESTIVE ORGANSOrgan: GALLBLADDERTissue: GallbladderType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.34808/72qp-cg74
title: Nontoxic multinodular goitre - Female, 46 - Tissue image [6300730028267071]

description: This is the histopathological image of THYROID GLAND tissue sample obtained in Medical University Gdańsk and deposited in ZMDL-GUMED. The sample image was taken using: Pannoramic 250 3DHistech slide scanner (20x magnification) and saved to DICOM format. The detailed information about the patient, sample, and diagnosis are as follows: Patient:Age: 46Clinical description: Thyroid goiter.Gender: FemaleDiagnosis:Classification: ICD-10_10-20Classification code: Chapter IV - Endocrine, nutritional and metabolic diseasesDiagnosis: Nontoxic multinodular goitreResult of the histopathological examination: Multinodular goiter.Sample:Material: FFPECollecting method: Surgical specimenTopography: THYROID AND OTHER ENDOCRINE GLANDSOrgan: THYROID GLANDTissue: Thyroid, NOSType of staining: positive/HEStaining: Not applicableAntibody: Not applicableTechnology:Equipment: Pannoramic 250 3DHistechLens: 20xOrganization:Source: Medical University Gdańsk
DOI: 10.6084/m9.figshare.19102751.v1
title: Supplementary Material for: Zinc Supplementation and the Prevention and Treatment of Sepsis in Young Infants: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Prematurity and low birth weight are major risk factors for neonatal sepsis. Zinc supplements have been previously shown to be beneficial in pregnancy and small for gestational age birth outcomes. There is sparse information, however, on the potential benefits of zinc supplementation to prevent or treat serious infections in this age group. <b><i>Objective:</i></b> The aim of this study was to assess the efficacy of preventive and therapeutic zinc supplementation in young infant (&lt;4 months) sepsis. <b><i>Methods:</i></b> MEDLINE, Cochrane CENTRAL, and other databases were searched from inception until 18 June 2021. Studies assessing preventive and therapeutic zinc supplementation in young infants in relation to incidence and outcomes of suspected sepsis were included. Meta-analyses of pooled effects were calculated for sepsis-related outcomes. <b><i>Results:</i></b> Eleven randomized controlled trials involving 2,819 infants were included. Eight studies reported therapeutic efficacy, whereas 3 evaluated preventive benefits of zinc supplementation. Preventive studies suggest a protective effect of zinc supplementation on neonatal mortality rate (NMR) (risk ratio (RR) 0.28; 95% CI 0.12–0.67, LOW certainty), but with no effect on the incidence of sepsis, both in preterm neonates. Among young infants, therapeutic zinc was associated with significant reductions in infant mortality-rate (RR 0.61; 95% CI 0.41–0.93, LOW certainty) and treatment failure (RR 0.61; 95% CI 0.44–0.85; LOW certainty). Therapeutic zinc supplementation in neonates was associated with significant increase in serum zinc concentrations (mean difference 81.97; 95% CI 34.57–129.37; LOW certainty), but without an effect on hospital stay or NMR. <b><i>Conclusion:</i></b> Zinc supplementation could potentially reduce mortality and treatment failure in young infants but has no noteworthy influence on hospital stay and in the prevention of sepsis. Further studies with larger sample sizes are needed to confirm the direction and magnitude of effects if any.
DOI: 10.6084/m9.figshare.19102751.v2
title: Supplementary Material for: Zinc Supplementation and the Prevention and Treatment of Sepsis in Young Infants: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Prematurity and low birth weight are major risk factors for neonatal sepsis. Zinc supplements have been previously shown to be beneficial in pregnancy and small for gestational age birth outcomes. There is sparse information, however, on the potential benefits of zinc supplementation to prevent or treat serious infections in this age group. <b><i>Objective:</i></b> The aim of this study was to assess the efficacy of preventive and therapeutic zinc supplementation in young infant (&lt;4 months) sepsis. <b><i>Methods:</i></b> MEDLINE, Cochrane CENTRAL, and other databases were searched from inception until 18 June 2021. Studies assessing preventive and therapeutic zinc supplementation in young infants in relation to incidence and outcomes of suspected sepsis were included. Meta-analyses of pooled effects were calculated for sepsis-related outcomes. <b><i>Results:</i></b> Eleven randomized controlled trials involving 2,819 infants were included. Eight studies reported therapeutic efficacy, whereas 3 evaluated preventive benefits of zinc supplementation. Preventive studies suggest a protective effect of zinc supplementation on neonatal mortality rate (NMR) (risk ratio (RR) 0.28; 95% CI 0.12–0.67, LOW certainty), but with no effect on the incidence of sepsis, both in preterm neonates. Among young infants, therapeutic zinc was associated with significant reductions in infant mortality-rate (RR 0.61; 95% CI 0.41–0.93, LOW certainty) and treatment failure (RR 0.61; 95% CI 0.44–0.85; LOW certainty). Therapeutic zinc supplementation in neonates was associated with significant increase in serum zinc concentrations (mean difference 81.97; 95% CI 34.57–129.37; LOW certainty), but without an effect on hospital stay or NMR. <b><i>Conclusion:</i></b> Zinc supplementation could potentially reduce mortality and treatment failure in young infants but has no noteworthy influence on hospital stay and in the prevention of sepsis. Further studies with larger sample sizes are needed to confirm the direction and magnitude of effects if any.
DOI: 10.6084/m9.figshare.19102751
title: Supplementary Material for: Zinc Supplementation and the Prevention and Treatment of Sepsis in Young Infants: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Prematurity and low birth weight are major risk factors for neonatal sepsis. Zinc supplements have been previously shown to be beneficial in pregnancy and small for gestational age birth outcomes. There is sparse information, however, on the potential benefits of zinc supplementation to prevent or treat serious infections in this age group. <b><i>Objective:</i></b> The aim of this study was to assess the efficacy of preventive and therapeutic zinc supplementation in young infant (&lt;4 months) sepsis. <b><i>Methods:</i></b> MEDLINE, Cochrane CENTRAL, and other databases were searched from inception until 18 June 2021. Studies assessing preventive and therapeutic zinc supplementation in young infants in relation to incidence and outcomes of suspected sepsis were included. Meta-analyses of pooled effects were calculated for sepsis-related outcomes. <b><i>Results:</i></b> Eleven randomized controlled trials involving 2,819 infants were included. Eight studies reported therapeutic efficacy, whereas 3 evaluated preventive benefits of zinc supplementation. Preventive studies suggest a protective effect of zinc supplementation on neonatal mortality rate (NMR) (risk ratio (RR) 0.28; 95% CI 0.12–0.67, LOW certainty), but with no effect on the incidence of sepsis, both in preterm neonates. Among young infants, therapeutic zinc was associated with significant reductions in infant mortality-rate (RR 0.61; 95% CI 0.41–0.93, LOW certainty) and treatment failure (RR 0.61; 95% CI 0.44–0.85; LOW certainty). Therapeutic zinc supplementation in neonates was associated with significant increase in serum zinc concentrations (mean difference 81.97; 95% CI 34.57–129.37; LOW certainty), but without an effect on hospital stay or NMR. <b><i>Conclusion:</i></b> Zinc supplementation could potentially reduce mortality and treatment failure in young infants but has no noteworthy influence on hospital stay and in the prevention of sepsis. Further studies with larger sample sizes are needed to confirm the direction and magnitude of effects if any.
DOI: 10.6084/m9.figshare.19102751.v4
title: Supplementary Material for: Zinc Supplementation and the Prevention and Treatment of Sepsis in Young Infants: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Prematurity and low birth weight are major risk factors for neonatal sepsis. Zinc supplements have been previously shown to be beneficial in pregnancy and small for gestational age birth outcomes. There is sparse information, however, on the potential benefits of zinc supplementation to prevent or treat serious infections in this age group. <b><i>Objective:</i></b> The aim of this study was to assess the efficacy of preventive and therapeutic zinc supplementation in young infant (&lt;4 months) sepsis. <b><i>Methods:</i></b> MEDLINE, Cochrane CENTRAL, and other databases were searched from inception until 18 June 2021. Studies assessing preventive and therapeutic zinc supplementation in young infants in relation to incidence and outcomes of suspected sepsis were included. Meta-analyses of pooled effects were calculated for sepsis-related outcomes. <b><i>Results:</i></b> Eleven randomized controlled trials involving 2,819 infants were included. Eight studies reported therapeutic efficacy, whereas 3 evaluated preventive benefits of zinc supplementation. Preventive studies suggest a protective effect of zinc supplementation on neonatal mortality rate (NMR) (risk ratio (RR) 0.28; 95% CI 0.12–0.67, LOW certainty), but with no effect on the incidence of sepsis, both in preterm neonates. Among young infants, therapeutic zinc was associated with significant reductions in infant mortality-rate (RR 0.61; 95% CI 0.41–0.93, LOW certainty) and treatment failure (RR 0.61; 95% CI 0.44–0.85; LOW certainty). Therapeutic zinc supplementation in neonates was associated with significant increase in serum zinc concentrations (mean difference 81.97; 95% CI 34.57–129.37; LOW certainty), but without an effect on hospital stay or NMR. <b><i>Conclusion:</i></b> Zinc supplementation could potentially reduce mortality and treatment failure in young infants but has no noteworthy influence on hospital stay and in the prevention of sepsis. Further studies with larger sample sizes are needed to confirm the direction and magnitude of effects if any.
DOI: 10.6084/m9.figshare.19102751.v3
title: Supplementary Material for: Zinc Supplementation and the Prevention and Treatment of Sepsis in Young Infants: A Systematic Review and Meta-Analysis

description: <b><i>Background:</i></b> Prematurity and low birth weight are major risk factors for neonatal sepsis. Zinc supplements have been previously shown to be beneficial in pregnancy and small for gestational age birth outcomes. There is sparse information, however, on the potential benefits of zinc supplementation to prevent or treat serious infections in this age group. <b><i>Objective:</i></b> The aim of this study was to assess the efficacy of preventive and therapeutic zinc supplementation in young infant (&lt;4 months) sepsis. <b><i>Methods:</i></b> MEDLINE, Cochrane CENTRAL, and other databases were searched from inception until 18 June 2021. Studies assessing preventive and therapeutic zinc supplementation in young infants in relation to incidence and outcomes of suspected sepsis were included. Meta-analyses of pooled effects were calculated for sepsis-related outcomes. <b><i>Results:</i></b> Eleven randomized controlled trials involving 2,819 infants were included. Eight studies reported therapeutic efficacy, whereas 3 evaluated preventive benefits of zinc supplementation. Preventive studies suggest a protective effect of zinc supplementation on neonatal mortality rate (NMR) (risk ratio (RR) 0.28; 95% CI 0.12–0.67, LOW certainty), but with no effect on the incidence of sepsis, both in preterm neonates. Among young infants, therapeutic zinc was associated with significant reductions in infant mortality-rate (RR 0.61; 95% CI 0.41–0.93, LOW certainty) and treatment failure (RR 0.61; 95% CI 0.44–0.85; LOW certainty). Therapeutic zinc supplementation in neonates was associated with significant increase in serum zinc concentrations (mean difference 81.97; 95% CI 34.57–129.37; LOW certainty), but without an effect on hospital stay or NMR. <b><i>Conclusion:</i></b> Zinc supplementation could potentially reduce mortality and treatment failure in young infants but has no noteworthy influence on hospital stay and in the prevention of sepsis. Further studies with larger sample sizes are needed to confirm the direction and magnitude of effects if any.
DOI: 10.6084/m9.figshare.19923437
title: The mechanisms of S-wave attenuation in grainstones

description: This work resolves the mechanisms of S-wave attenuation in water-saturated grainstones.
DOI: 10.6084/m9.figshare.19923437.v2
title: The mechanisms of S-wave attenuation in grainstones

description: This work resolves the mechanisms of S-wave attenuation in water-saturated grainstones.
DOI: 10.6084/m9.figshare.19923437.v1
title: The mechanisms of S-wave attenuation in a grainstone

description: This work resolves the mechanisms of S-wave attenuation in water-saturated D'Euville limestone.
DOI: 10.5281/zenodo.6524750
title: The OPS-SAT case dataset

description: The "OPS-SAT case" dataset is the official dataset of <strong>ESA's Kelvins</strong> <strong>"the OPS-SAT case" challenge, </strong>created in collaboration<strong> with ESA's Phi-lab </strong>and <strong>ESA's OPS-SAT spacecraft operations team</strong>. It consists of<strong> 26 raw and unprocessed images</strong> of Earth that have been taken by the OPS-SAT cube-sat using its on-board camera. The images have a resolution of around <strong>2048x1944 </strong>or similar and are provided in <strong>.png</strong> format. The goal of the competition is, given a model of a neural network (in this case the <strong>EfficientNet-Lite0</strong>), to provide best possible network parameters to perform an <strong>on-board classification</strong> task. For each of the 8 target classes, there are only 10 labelled images provided, severely limiting the number of "shots" that the neural network has on learning. The size of the labeled patches is <strong>200x200</strong> pixels and the labels are related to the following types of landcover/content: <strong>Agricultural, Cloud, Mountain, Natural, River, Sea_Ice, Snow </strong>and <strong>Water.</strong> More details about the competition setup and solution evaluation are on the Kelvins competition platform. The following publication outlines the generation of the dataset: Derksen, D., Meoni, G., Lecuyer, G., Mergy, A., Märtens, M. and Izzo, D. Few-Shot Image Classification Challenge On-Board. NEURIPS2021
DOI: 10.5281/zenodo.6524749
title: The OPS-SAT case dataset

description: The "OPS-SAT case" dataset is the official dataset of <strong>ESA's Kelvins</strong> <strong>"the OPS-SAT case" challenge, </strong>created in collaboration<strong> with ESA's Phi-lab </strong>and <strong>ESA's OPS-SAT spacecraft operations team</strong>. It consists of<strong> 26 raw and unprocessed images</strong> of Earth that have been taken by the OPS-SAT cube-sat using its on-board camera. The images have a resolution of around <strong>2048x1944 </strong>or similar and are provided in <strong>.png</strong> format. The goal of the competition is, given a model of a neural network (in this case the <strong>EfficientNet-Lite0</strong>), to provide best possible network parameters to perform an <strong>on-board classification</strong> task. For each of the 8 target classes, there are only 10 labelled images provided, severely limiting the number of "shots" that the neural network has on learning. The size of the labeled patches is <strong>200x200</strong> pixels and the labels are related to the following types of landcover/content: <strong>Agricultural, Cloud, Mountain, Natural, River, Sea_Ice, Snow </strong>and <strong>Water.</strong> More details about the competition setup and solution evaluation are on the Kelvins competition platform. The following publication outlines the generation of the dataset: Derksen, D., Meoni, G., Lecuyer, G., Mergy, A., Märtens, M. and Izzo, D. Few-Shot Image Classification Challenge On-Board. NEURIPS2021
DOI: 10.15151/esrf-es-874153411
title: Universities of St. Andrews, Dundee, Glasgow, and Aberdeen

description: The Dundee/St Andrews/Glasgow/Aberdeen BAG research interests fall into two broad areas. Firstly, we use structural information to understand mechanisms of fundamental biological processes, protein engineering, enzymes, and biological chemistry. Secondly, we utilize structural insights to guide target selection and development of lead compounds for drug development. Fundamental insights obtained into biological processes are often closely coupled to target identification and development of tools, reagents, or inhibitors, which feed into a range of biomedical applications. Our research relies heavily on high quality, reliable and tunable synchrotron radiation, along with state-of-the-art optics, detectors, sample changers, and computation, to support determination of new structures, as well as collect high resolution diffraction data to provide the level of accuracy important in structure-guided drug design.
DOI: 10.15151/esrf-es-816054245
title: Determining symmetry and crystal structure of kagome bilayer compound Fe3Sn2

description: We propose high-resolution x-ray diffraction on the topological kagome metal Fe3Sn2. This trigonal compound exhibits ferromagnetic order below 650 K and undergoes a spin reorientation toward the ab-plane below 200 K. At low temperatures, magnetic order and orbital nematicity violate three-fold symmetry and creates preconditions for the symmetry lowering of the crystal structure that we seek to probe in the high-resolution experiment. By temperature-dependent diffraction studies, we will address the origin of the spin reorientation in Fe3Sn2 and gauge changes in the crystal structure that affect its topological energy bands. This will be an essential step to quantify magnetoelastic coupling in the family of Fe-Sn kagome metals.